Viewing Study NCT06888505

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:29 AM
Ignite Modification Date: 2026-01-16 @ 3:50 PM
Study NCT ID: NCT06888505
Status: COMPLETED
Last Update Posted: 2025-09-18
First Post: 2025-03-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Dapagliflozin to Prevent Anthracycline-Induced Cardiotoxicity
Sponsor: Hawler Medical University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anthracyclines-Induced Cardiotoxicity View
None Cardiotoxicity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cardiotoxicity View
None Anthracycline-induced cardiotoxicity View
None Dapagliflozin View
None SGLT2 inhibitors View
None cardio-oncology View
None Cardiac biomarkers in chemotherapy View
None Heart failure in cancer patients View